[
    [
        {
            "time": "2021-08-31",
            "original_text": "华熙生物2021年中报点评：21H1营收+104%，功能性护肤驱动收入增长！【东吴医药&零售社服】",
            "features": {
                "keywords": [
                    "华熙生物",
                    "2021年中报",
                    "营收+104%",
                    "功能性护肤"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "护肤品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物2021年中报点评：21H1营收+104%，功能性护肤驱动收入增长！【东吴医药&零售社服】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "华熙生物上半年净利3.61亿销售费用8.97亿，护肤品贡献6成业绩，股价一个月腰斩 盈利能力下降",
            "features": {
                "keywords": [
                    "华熙生物",
                    "净利3.61亿",
                    "销售费用8.97亿",
                    "护肤品贡献6成业绩",
                    "股价腰斩"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "护肤品"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华熙生物上半年净利3.61亿销售费用8.97亿，护肤品贡献6成业绩，股价一个月腰斩 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "华熙生物(688363)：营收增速为预告上限 四驾马车共同助力长效发展",
            "features": {
                "keywords": [
                    "华熙生物",
                    "营收增速",
                    "四驾马车",
                    "长效发展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华熙生物(688363)：营收增速为预告上限 四驾马车共同助力长效发展",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "【开源零售|华熙生物：中报业绩同比+35%，终端业务高速增长】",
            "features": {
                "keywords": [
                    "华熙生物",
                    "中报业绩",
                    "同比+35%",
                    "终端业务高速增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "零售",
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【开源零售|华熙生物：中报业绩同比+35%，终端业务高速增长】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "华熙生物(688363)：研发驱动 营销迭代 高速增长",
            "features": {
                "keywords": [
                    "华熙生物",
                    "研发驱动",
                    "营销迭代",
                    "高速增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华熙生物(688363)：研发驱动 营销迭代 高速增长",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "总营收超19亿增幅超104% 华熙生物2021上半年延续高增长态势",
            "features": {
                "keywords": [
                    "华熙生物",
                    "总营收超19亿",
                    "增幅超104%",
                    "高增长态势"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "总营收超19亿增幅超104% 华熙生物2021上半年延续高增长态势",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "华熙生物(688363)：医美产品矩阵细分化 功效护肤业务强势增长",
            "features": {
                "keywords": [
                    "华熙生物",
                    "医美产品矩阵",
                    "功效护肤业务",
                    "强势增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医美",
                    "护肤品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物(688363)：医美产品矩阵细分化 功效护肤业务强势增长",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "医美产业系列跟踪：医美广告监管执法指南出台 规范行业长期健康发展",
            "features": {
                "keywords": [
                    "医美产业",
                    "广告监管",
                    "执法指南",
                    "健康发展"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医美产业系列跟踪：医美广告监管执法指南出台 规范行业长期健康发展",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "【浙商医美】华熙生物：营利双增，三大板块驱动美丽经济腾飞",
            "features": {
                "keywords": [
                    "华熙生物",
                    "营利双增",
                    "三大板块",
                    "美丽经济腾飞"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医美",
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商医美】华熙生物：营利双增，三大板块驱动美丽经济腾飞",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "华熙生物：2021半年度净利润约3.61亿元，同比增加35.01%",
            "features": {
                "keywords": [
                    "华熙生物",
                    "净利润",
                    "同比增加35.01%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物：2021半年度净利润约3.61亿元，同比增加35.01%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]